Madrigal Pharmaceuticals, Inc. MDGL Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Madrigal Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s interest coverage?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported interest coverage of -11.7× in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s interest coverage changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s interest coverage increased by 61.2% year-over-year, from -30.1× to -11.7×.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s interest coverage?
- Over 3 years (2022 to 2025), Madrigal Pharmaceuticals, Inc.'s interest coverage has grown at a -43.4% compound annual growth rate (CAGR), from -74.1× to -13.5×.
- What does interest coverage mean?
- How many times the company's operating profit covers its interest bill.
- How do you interpret interest coverage?
- Higher is safer; below ~2× is a warning that earnings provide little cushion against the debt burden. Debt-free companies have no interest expense and the ratio is left blank.
- How does interest coverage compare across companies?
- Comparable across leveraged non-financials; less relevant for net-cash companies with negligible interest.